|

GENE THERAPY
THE STATE OF THE ART
Dr. Abdel Aziz El Bayoumi
Professor of Genetics
Dr. Khalid Al Ali
Lecturer of Genetics
Department of Biological Sciences
University of Qatar, Doha
|
|
11.1.1 HIV Life Cycle
HIV is a member of lentivirus family of retroviruses. RNA
viruses that integrate into host chromosome through a double-stranded DNA intermediate
provirus. Therefore AIDS is essentially an acquired genetic disease capable of suppressing
the immune function (Poeschla, 1996)
All retroviruses contain gog, pol, and env genes. HIV contains numerous other genes including
tat, rev, nef, vpu, vif, and vpr which are translated from differentially messenger RNA
(mRNA) transcripts. Some of the regulatory functions for these genes are defined, while
others are still obscure. (Figure 16)

Figure 16 : HIV genome
Full understanding of the biologic function of these genes and HIV – host interactions
facilitate the design for gene therapy treatments for the AIDS. The complexity of HIV-host
interactions depends on the functional integration of HIV into the fundamental cells of the
immune system. The cellular receptors used for HIV binding and entry are essential receptors
for immune function. HIV utilizes replication
and gene expression. For example transcriptional factors that regulate activation of T cells
can bind to the viral promoter regions within HIV LTR and regulate virus gene expression.
Also, regulatory gene products from HIV, such as tat, can bind to host gene – promoter
regions and induce expression of regulatory factors that are important for the immune
system. HIV integrates into the host genomes and also functionally integrates into the
complex regulatory machinery of the immune system cells (Brother, 1996).
|